COMBINATION THERAPY FOR TREATING CANCER

To provide compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone.SOLUTION: The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and...

Full description

Saved in:
Bibliographic Details
Main Authors HEIKE KEILHACK, SARAH KATHLEEN KNUTSON, KEVIN WAYNE KUNTZ
Format Patent
LanguageEnglish
Japanese
Published 12.08.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone.SOLUTION: The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly to compositions comprising anticancer agents such as prednisone, and to methods of combination therapy for administering to subjects in need thereof for treatment of cancer.SELECTED DRAWING: Figure 7 【課題】ヒトヒストンメチルトランスフェラーゼＥＺＨ２のインヒビターと、１種以上の他の治療剤、特に、プレドニゾンなどの抗がん剤とを含む組成物を提供すること【解決手段】本発明は、ヒトヒストンメチルトランスフェラーゼＥＺＨ２のインヒビターと、１種以上の他の治療剤を含む組成物に関するものであり、特に、プレドニゾンなどの抗がん剤を含む組成物に関するものであり、そしてがんの処置のためにそれを必要とする対象に投与するための組合せ治療の方法に関するものである。【選択図】図７
Bibliography:Application Number: JP20210079088